Skip to main content
Theraclion SA logo

Theraclion SA — Investor Relations & Filings

Ticker · ALTHE ISIN · FR0010120402 LEI · 9695007X7HA7A1GCYD29 PA Manufacturing
Open in API
Filings indexed 399 across all filing types
Latest filing 2015-08-31 Regulatory Filings
Country FR France
Listing PA ALTHE

About Theraclion SA

https://www.theraclion.com/?_ga=2.14878…

Theraclion SA is a medical device company specializing in the development and marketing of non-invasive therapeutic solutions using High-Intensity Focused Ultrasound (HIFU). The company's technology, known as echotherapy, provides a non-surgical alternative for tissue ablation. Its flagship product, SONOVEIN®, is a robotic solution for the non-invasive treatment of varicose veins. The system uses external ultrasound beams to ablate the target vein without incisions, catheters, or sedation, allowing for immediate patient recovery. Theraclion also developed ECHOPULSE®, a system for the treatment of thyroid nodules and breast fibroadenomas. The company's core focus is on providing precise, non-invasive treatments that reduce risks and recovery time compared to traditional surgical procedures.

Recent filings

Filing Released Lang Actions
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.)
Regulatory Filings Classification · 85% confidence The document is a press release dated August 31, 2015, announcing commercial agreements for the Echopulse system and the publication of supporting clinical data regarding thyroid nodule treatment efficiency. It details business developments (new commercial agreements in Germany) and scientific updates (publication of a study in the journal Röfo). This content structure—announcing business milestones and referencing new scientific/clinical data—is characteristic of an Earnings Release (ER) or a general business update, but since it is not explicitly an earnings report summary (no P&L, balance sheet figures, or quarterly period mentioned), and it focuses on operational progress and scientific validation, it fits best as a general business announcement. However, none of the definitions perfectly capture a general business/product update that isn't explicitly about financing (CAP), management change (MANG), or a formal regulatory filing (RNS). Given the focus on announcing key operational achievements (commercialization) and clinical validation, it functions as a significant business update. Since it is not a formal regulatory filing (like 10-K or IR) and doesn't fit the specific categories like DIV, DIRS, or MANG, the most appropriate classification for a significant, non-standard business announcement that isn't a formal report is the general Regulatory Filings/Announcements category (RNS), or potentially an Earnings Release (ER) if it were near a reporting period, but ER is defined as 'initial announcement of quarterly/periodical financial results (key highlights only)'. This document focuses on commercial and clinical milestones, not financial results highlights. Therefore, RNS (Regulatory Filings - general fallback) is the safest classification for a press release detailing operational progress and clinical publication announcements.
2015-08-31 English
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …)
Regulatory Filings Classification · 95% confidence The document is a press release dated August 31, 2015, announcing commercial agreements for the Echopulse system in Europe for thyroid nodule treatment and the publication of medium-term clinical data in a medical journal. It details business updates (new contracts) and scientific findings. This type of announcement, which communicates key business and operational news outside of mandatory periodic financial reports (like 10-K or IR), typically falls under a general regulatory announcement or press release category. Since it is not a formal financial report (10-K, IR, MRQ), a specific management discussion (MDA), or a dedicated earnings release (ER), the most appropriate classification is Regulatory Filings (RNS), which serves as a general category for significant, non-standard corporate announcements.
2015-08-31 French
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.)
Regulatory Filings Classification · 95% confidence The document is a press release dated July 15th, 2015, announcing that Theraclion has initiated a clinical trial for its Echopulse® procedure. It details the progress, quotes management and a physician, and provides company background. This type of announcement, which reports on operational progress, clinical developments, or strategic updates rather than formal financial results (like 10-K or ER) or mandatory regulatory filings, fits best under the general category of Investor Relations or Regulatory Filings. Since it is a specific operational update that doesn't match the definitions for LTR (Legal), MANG (Management Change), or CAP (Financing), and it is not a formal report itself, it is classified as a general Regulatory Filing (RNS) as it serves as a broad communication to the market regarding company activity, or potentially Investor Relations (IR) if that category were broader. Given the provided definitions, RNS (Regulatory Filings - general regulatory announcements and fallback) is the most appropriate fit for a non-financial, non-management, non-legal operational press release.
2015-07-15 English
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …)
Regulatory Filings Classification · 95% confidence The document is a press release dated July 15, 2015, announcing that the company Theraclion has started a clinical study for a new, faster treatment procedure using its Echopulse® system. It details the initiation of the study, early patient recruitment, and quotes management regarding product development strategy. This type of announcement, focusing on operational milestones, clinical progress, or strategic updates outside of mandatory financial reporting (like 10-K or ER), typically falls under general corporate news or regulatory updates. Since it is not a formal financial report (10-K, IR, ER, MRQ), nor a specific event like a dividend (DIV) or management change (MANG), it is best classified as a general Regulatory Filing (RNS) as it is an official announcement to the market regarding company activity, or potentially an Investor Presentation (IP) if it were structured as a slide deck, but given the press release format, RNS is the most appropriate general category for non-standard announcements.
2015-07-15 French
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Capital/Financing Update Classification · 99% confidence The document announces that Theraclion has received a new financing of 1.1 M€ from Bpifrance under the 'Innovation Stratégique Industrielle' program. This announcement details a specific corporate financing event, including the amount, the source (Bpifrance), and the context (collaboration project TUCE). This clearly falls under the category of updates on company fundraising or financing activities, which corresponds to the Capital/Financing Update (CAP) code. It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it is highly specific to a financing event.
2015-07-09 French
Communicated under the obligation to provide permanent information / Other communications
Capital/Financing Update Classification · 99% confidence The document announces that Theraclion has received an additional financing of €1.1 million in the form of a repayable advance from Bpifrance, following the achievement of a project milestone. This content directly relates to the company securing new funding and changes in its capital structure/financing activities. This aligns perfectly with the definition for Capital/Financing Update (CAP). It is not an earnings release (ER), an annual report (10-K), or a general regulatory filing (RNS), as it details a specific financing event.
2015-07-09 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.